| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 152.81▲ | 152.61▲ | 153.18▼ | 159.92▼ | 165.94▼ |
| MA10 | 152.72▲ | 153.65▼ | 155.23▼ | 162.00▼ | 166.76▼ |
| MA20 | 152.72▲ | 155.69▼ | 158.92▼ | 169.55▼ | 155.52▼ |
| MA50 | 153.13▼ | 160.39▼ | 161.57▼ | 168.24▼ | 145.91▲ |
| MA100 | 155.25▼ | 162.14▼ | 168.53▼ | 154.16▼ | 134.63▲ |
| MA200 | 158.58▼ | 168.97▼ | 171.61▼ | 146.85▲ | 126.86▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.066▲ | -0.175▼ | -0.690▼ | -2.352▼ | -0.538▼ |
| RSI | 50.691▲ | 26.157▼ | 24.270▼ | 33.996▼ | 48.893▼ |
| STOCH | 50.041 | 29.459 | 20.675 | 12.605▼ | 50.611 |
| WILL %R | -41.772 | -68.791 | -80.661▼ | -93.272▼ | -92.933▼ |
| CCI | 36.687 | -57.016 | -104.742▼ | -128.510▼ | -90.842 |
|
Wednesday, August 12, 2026 09:40 AM
Neurocrine Biosciences (NBIX) stock dips as safety concerns linked to the company's newly acquired rare disease drug, Vykat XR, resurface. Read more here.
|
|
Wednesday, August 12, 2026 06:38 AM
Neurocrine Biosciences (NASDAQ:NBIX) shares dropped 5.8% following reports of patient deaths and serious adverse events potentially associated with Vykat, a treatment for Prader-Willi syndrome.
|
|
Wednesday, August 12, 2026 05:31 AM
Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/08/26 | 155.47 | 155.81 | 150.45 | 152.85 | 1,091,407 |
| 12/08/26 | 159.72 | 159.98 | 154.8575 | 156.49 | 2,093,606 |
| 11/08/26 | 165.46 | 165.46 | 161.78 | 161.94 | 723,314 |
| 10/08/26 | 161.52 | 165.15 | 161.52 | 164.92 | 935,217 |
| 07/08/26 | 161.53 | 164.7599 | 159.68 | 163.41 | 970,908 |
| 06/08/26 | 161.28 | 162.51 | 158.475 | 159.82 | 1,366,018 |
| 05/08/26 | 168.55 | 168.55 | 161.30 | 161.50 | 1,291,983 |
| 04/08/26 | 166.89 | 169.015 | 165.73 | 166.06 | 1,119,146 |
| 03/08/26 | 167.25 | 170.8788 | 164.01 | 166.23 | 1,515,940 |
| 31/07/26 | 184.34 | 185.55 | 164.56 | 166.80 | 4,582,490 |
|
|
||||
|
|
||||
|
|